Welcome to the ResMed Lumis VPAP User Guide
The ResMed Lumis Series VPAP & VPAP ST are innovative bilevel positive airway pressure devices designed to provide non-invasive ventilation to patients. These devices, including the Lumis 100 VPAP S, Lumis 100 VPAP ST, and Lumis 150 VPAP ST, serve patients with different forms of respiratory insufficiency and obstructive sleep apnoea (OSA).
It’s essential to read the user guide thoroughly before operating the device to ensure safety and proper use. This guide includes pertinent information regarding the device’s intended use, and while it’s a valuable resource, users should always prioritize the advice of their prescribing physician.
Indications for Use
The Lumis VPAP devices are indicated for individuals weighing more than 13kg who suffer from respiratory insufficiency or OSA. The Lumis 150 VPAP ST is additionally suitable for iVAPS mode in patients weighing more than 30kg. Whether intended for home or hospital settings, these VPAP devices come equipped with humidifiers designed for single-patient use in homes or multiple uses in hospital or institutional environments.
Clinical Benefits
The devices’ use for OSA includes a significant reduction in apnoeas, hypopnoeas, and the general symptoms of sleepiness while also enhancing the quality of life. Bilevel therapy is particularly beneficial for those dealing with respiratory insufficiency, as it can improve survival rates, daytime symptoms, blood gases, health-related quality of life, sleep quality, and may decrease the number of hospitalizations and instances of dyspnoea. Moreover, the devices have been demonstrated to provide substantial humidification benefits, reducing the side effects generally related to positive airway pressure interventions.
Intended Patient Population
The VPAP devices are suitable for a broad range of respiratory disorders. This includes patients with obstructive pulmonary diseases, such as chronic obstructive pulmonary disease (COPD), restrictive pulmonary diseases including conditions of the lung parenchyma, diseases of the chest wall, neuromuscular diseases, and central respiratory regulation diseases. They are also indicated for patients with OSA and obesity hypoventilation syndrome (OHS).
For more detailed information about operating procedures, care and maintenance, troubleshooting, technical specifications, and more, users are encouraged to diligently review the entire user guide.
References:
Chat: Powered By VoiceSphere